ENvue Medical, Inc.
FEED
$1.16
$0.000.00%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.55M | 2.69M | 2.34M | 2.66M | 2.56M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.55M | 2.69M | 2.34M | 2.66M | 2.56M |
| Cost of Revenue | 2.40M | 1.88M | 1.59M | 1.45M | 1.05M |
| Gross Profit | 153.00K | 806.00K | 750.00K | 1.21M | 1.51M |
| SG&A Expenses | 10.13M | 8.18M | 6.82M | 4.76M | 4.18M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.29M | 12.13M | 10.51M | 7.53M | 6.14M |
| Operating Income | -11.74M | -9.45M | -8.17M | -4.87M | -3.58M |
| Income Before Tax | -19.12M | -7.27M | -8.81M | -5.59M | -3.69M |
| Income Tax Expenses | -307.00K | 117.00K | 85.00K | 27.00K | 19.00K |
| Earnings from Continuing Operations | -18.81 | -7.39 | -8.90 | -5.61 | -3.71 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -18.81M | -7.39M | -8.90M | -5.61M | -3.71M |
| EBIT | -11.74M | -9.45M | -8.17M | -4.87M | -3.58M |
| EBITDA | -10.84M | -8.81M | -7.79M | -4.85M | -3.58M |
| EPS Basic | -54.16 | -79.55 | -82.20 | -108.35 | -92.31 |
| Normalized Basic EPS | -31.17 | -53.48 | -56.10 | -67.96 | -57.33 |
| EPS Diluted | -54.16 | -79.55 | -82.20 | -108.35 | -92.31 |
| Normalized Diluted EPS | -31.17 | -53.48 | -56.10 | -67.96 | -57.33 |
| Average Basic Shares Outstanding | 2.51M | 1.44M | 865.40K | 406.10K | 368.20K |
| Average Diluted Shares Outstanding | 2.51M | 1.44M | 865.40K | 406.10K | 368.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |